Carboplatin is an alkylating agent which binds covalently to DNA. It modifies the cell cycle by interfering with DNA structure and function. Carboplat Injection is indicated for the initial treatment of advanced ovarian carcinoma of epithelial origin in established combination with other approved chemotherapeutic agents. It is also indicated for the palliative treatment of patient with ovarian carcinoma recurrent after prior chemo therapy.
Product Name | Carboplat |
Generic Name | Carboplatin |
Formulation | IV Infusion |
Available Pack Size | 150mg, 450mg |
Available Strength | 10mg/ml |